Avoiding surgery for thyroid eye disease

Eye

Volumn 20, Issue 10, 2006, Pages 1171-1177

  Meyer, P A R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Compressive optic neuropathy; Cyclosporin A; Methylprednisolone; Strabismus; Thyroid eye disease

Indexed keywords

ALENDRONIC ACID; ANTIGEN; CALCIUM; CYCLOSPORIN A; ETIDRONIC ACID; IMMUNOMODULATING AGENT; METHYLPREDNISOLONE; OMEPRAZOLE; PREDNISOLONE; RANITIDINE; STEROID; TACROLIMUS;

ADIPOSE TISSUE; ADULT; AGED; AUTOIMMUNITY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORNEA INJURY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EXTRAOCULAR MUSCLE; EYE MOVEMENT; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; INFECTION; INFLAMMATION; MALE; MALIGNANT NEOPLASTIC DISEASE; MYOFIBROSIS; MYOPATHY; MYOSITIS; NERVE COMPRESSION; OPTIC NERVE; ORBIT; OUTCOME ASSESSMENT; PATIENT CODING; SMOKING; THYROID DISEASE; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

EID: 33749480918     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702393     Document Type: Conference Paper

References (12)

1. Heufelder AE. Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord 2000; 1(1-2): 87-95.
2. Ludgate M, Baker G. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 2002; 127(2): 193-198.
3. Ludgate M, Crisp M, Lane C, Costagliola S, Vassart G, Weetman A et al. The thyrotropin receptor in thyroid eye disease. Thyroid 1998; 8(5): 411-413.
4. Weetman AP. Autoimmune Endocrine Disease. Cambridge University Press: Cambridge, 1991.
5. Feldon SE, Park DJ, O'Loughlin CW, Nguyen VT, Landskroner-Eiger S, Chang D et al. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy. Invest Ophthalmol Vis Sci 2005; 46(1): 3913-3921.
6. Huber GK, Concepcion ES, Graves PN, Davies TF. Positive regulation of human thyrotropin receptor mRNA by thyrotropin. J Clin Endocrinol Metab 1991; 72(6): 1394-1396.
7. Weetman AP, Pickerill AP, Watson P, Chatterjee VK, Edwards OM. Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse. Q J Med 1994; 87: 337-341.
8. Bartalena L, Tanda ML, Piantanida E, Lai A, Pinchera A. Relationship between management of hyperthyroidism and course of the ophthalmopathy. J Endocrinol Invest 2004; 27(3): 288-294.
9. Chatila TA, Geha RS. Superantigens. In: Lachmann PPJ, Peters DK, Rosen FS and Walport MJ (eds). Clinical Aspects of Immunology, 5th ed. Blackwell: Boston, 1993.
10. Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996; 80: S40-S45 (Review).
11. Losa Garcia JE, Mateos Rodriguez F, Jimenez Lopez A, Garcia Salgado MJ, Martin de Cabo MR, Perez Losada J et al. Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages. Respir Med 1998; 92(5): 722-728.
12. Fitzsimons R, Fraco, White FJ. Functional scoring of the field of binocular single vision. Ophthalmology 1990; 97: 33-35.